BMY - Bristol-Myers Squibb Co
301
$58.11
-$1.26 (-2.122%)
At market close
$58.24
$0.13 (0.216%)
After Hours 3/19/26, 10:38 PM
Score3.86/5
Ownership Breakdown
Type | % Ownership | Market Value |
|---|---|---|
Insider | 0.02% | $28.16M |
Institutional | 83.30% | $98.58B |
Common & Other | 16.67% | $19.73B |
Insider Transactions
Buy Transactions
Sell Transactions
Insider Transaction Details
Sell, Exercise, Grant, Buy
Buy/Sell | Total Amount | Officer | Stock Price | Regulatory Filing Share Count | Regulatory Filing Shares | Date |
|---|
Sell | $119,778.96 | Poole Ahn AmandaExecutive VP, Chief People Officer, Member of the Leadership Team | $60.13 | -1,992.00 | 7,094.00 | 2026-03-10 |
Exercise | $0.00 | Poole Ahn AmandaExecutive VP, Chief People Officer, Member of the Leadership Team | $0.00 | 6,436.00 | 10.72K | 2026-03-10 |
Sell | $1,276,499.77 | Boerner Christopher S.Chairman of the Board, CEO | $60.13 | -21.23K | 21.45K | 2026-03-10 |
Exercise | $0.00 | Boerner Christopher S.Chairman of the Board, CEO | $0.00 | 71.54K | 34.82K | 2026-03-10 |
Sell | $76,665.75 | Short Bartie Wendy | $60.13 | -1,275.00 | 7,917.00 | 2026-03-10 |
Exercise | $0.00 | Short Bartie Wendy | $0.00 | 5,883.00 | 10.95K | 2026-03-10 |
Sell | $81,656.54 | Holzer Phil MSVP, Controller | $60.13 | -1,358.00 | 17.36K | 2026-03-10 |
Exercise | $0.00 | Holzer Phil MSVP, Controller | $0.00 | 6,191.00 | 20.48K | 2026-03-10 |
Sell | $83,640.83 | Hoch LynellePresident, Cell Therapy Organization, Member of the Leadership Team | $60.13 | -1,391.00 | 8,210.00 | 2026-03-10 |
Exercise | $0.00 | Hoch LynellePresident, Cell Therapy Organization, Member of the Leadership Team | $0.00 | 8,192.00 | 12.22K | 2026-03-10 |